美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA210134"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0002-6145-11 0002-6145 HUMAN PRESCRIPTION DRUG Baqsimi glucagon POWDER NASAL 20190806 N/A NDA NDA210134 Eli Lilly and Company GLUCAGON 3 mg/1 1 TUBE in 1 CARTON (0002-6145-11) / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)
0002-6145-27 0002-6145 HUMAN PRESCRIPTION DRUG Baqsimi glucagon POWDER NASAL 20190806 N/A NDA NDA210134 Eli Lilly and Company GLUCAGON 3 mg/1 2 TUBE in 1 CARTON (0002-6145-27) / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)
0548-8352-02 0548-8352 HUMAN PRESCRIPTION DRUG Baqsimi glucagon POWDER NASAL 20240207 N/A NDA NDA210134 Amphastar Pharmaceuticals, Inc. GLUCAGON 3 mg/1 2 TUBE in 1 CARTON (0548-8352-02) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE
0548-8351-01 0548-8351 HUMAN PRESCRIPTION DRUG Baqsimi glucagon POWDER NASAL 20240315 N/A NDA NDA210134 Amphastar Pharmaceuticals, Inc. GLUCAGON 3 mg/1 1 TUBE in 1 CARTON (0548-8351-01) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase